PetMed Express, Inc. (PETS)

Market Cap	67.86M
Revenue (ttm)	247.01M
Net Income (ttm)	357,000
Shares Out	20.63M
EPS (ttm)	0.02
PE Ratio	192.80
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	119,148
Open	3.300
Previous Close	3.370
Day's Range	3.250 - 3.350
52-Week Range	2.900 - 6.850
Beta	0.78
Analysts	Sell
Price Target	3.35 (+1.82%)
Earnings Date	Aug 5, 2025

About PETS

PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthri...

• Industry: Pharmaceutical Retailers
• Sector: Healthcare
• Founded: 1996
• Employees: 287
• Stock Exchange: NASDAQ
• Ticker Symbol: PETS
• Website: https://www.1800petmeds.com

Analyst Summary

According to 2 analysts, the average rating for PETS stock is "Sell." The 12-month stock price target is $3.35, which is an increase of 1.82% from the latest price.

Price Target

$3.35

(1.82% upside)

Analyst Consensus: Sell